No recent analyst price targets found for VYYRF.
Latest News for VYYRF

Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt
Purity Exceeding Pharmaceutical Grade, 98.8% BaSO4
TheNewswire • Mar 4, 2026

Voyageur Pharmaceuticals Announces Collaboration with Bayer
Calgary, Alberta, Canada – TheNewswire – February 23, 2026 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM ) ( OTC Pink:VYYRF) (" Voyageur " or the " Company ") a Canadian developer of pharmaceutical-grade barium and iodine for medical imaging contrast media drugs, is pleased to announce that it has signed, effective February 22, 2026, a collaboration and funding agreement (the “ Agreement ”) with Bayer (“ Bayer ”), with…
TheNewswire • Feb 23, 2026
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for VYYRF.
Senate Trading
No Senate trades found for VYYRF.
U.S. House Trading
No House trades found for VYYRF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
